Treace Medical Concepts Inc (TMCI) Form 4 Filed by John T. Treace, Mar 12, 2024
SEC Form 4 · No Market Transaction
Tax Withholding
Shares withheld for tax obligations.
Equity Position
11.1M sh
11,124,309 → 11,117,224
Equity Change
-0.1%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| John T. Treace CIK 0001856380 |
Director
CEO
10% Owner
|
John T. Treace at Treace Medical Concepts Inc
Full insider history
Bought (12 mo)
$1,351,631
Sold (12 mo)
—
More from this insider at Treace Medical Concepts Inc
| 2026-08-24 | Buy | +$246,654 | View |
| 2026-06-11 | Buy | +$210,968 | View |
| 2026-06-01 | Buy | +$177,915 | View |
| 2026-05-28 | Buy | +$340,589 | View |
| 2026-05-14 | Buy | +$375,505 | View |
Non-Derivative Securities Transactions
Footnotes (4)
- F1
- Includes 201,667 restricted stock units Show more
- F2
- Includes 196,646 restricted stock units Show more
- F3
- The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee. Show more
- F4
- The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee. Show more
Related filings at Treace Medical Concepts Inc
Institutional Holders
13F holders · Jun 30, 2026
115
institutional managers reporting a position
Largest by reported value
- Armistice Capital, Llc $25.3M
- Bank Of America Corporation $13.2M
- Gagnon Securities Llc $12.1M
5%+ Holders · 13D/G
4 filers
-
John T. Treace 19.2%
Other insiders at Treace Medical Concepts Inc
GET /v1/forms/4/0000950170-24-030472
API docs
View Original SEC Filing